Dispensed: Venture-back insurance startup Bright Health's 2018 results, a dispute between 2 drug giants, and the quest for a male birth control drug
had the story on the newest test out using the Helix DNA kit. It looks at risk of some of the same conditions 23andMe looks at, but includes genetic counseling and requires a doctor's sign-off. Here's what you need to know about it.
According to state filings, Bright lost $17.5 million in 2018, the same as in 2017. At the same time, it doubled its membership base to more than 24,000 from 12,000. Startups have attracted massive funding in the past few years to build new kinds of health-insurance plans — with the help of technology.
The pharmaceutical company Amgen and biotech Mirati are backing two new drugs that are raising those hopes again, though it's still early days. The biotech AveXis develops cutting-edge"gene therapy" products that could be powerful and long-lasting medical treatments.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Texas A.G. investigating Chick-Fil-A's exclusion at airportTexas' attorney general opens investigation into San Antonio's decision to exclude Chick-fil-A from opening airport concession facilities due to the fast-food chain owners' record on LGBT issues. - NBCOUT
Read more »
A Berkeley-stacked startup backed by Silicon Valley's top tech hub is developing male birth control that experts call promisingYour Choice Therapeutics is working on hormone-free contraception with science developed at UC Berkeley. The startup recently debuted at Y Combinator.
Read more »
Novartis, Amgen in dispute over migraine drug partnershipSwiss drugmaker Novartis AG sued Amgen Inc on Thursday, accusing the U.S. biotec...
Read more »
FDA’s Gottlieb heads back to AEI to tackle drug pricesScott Gottlieb, the FDA commissioner who will step down Friday, plans to return to the American Enterprise Institute to write about and research drug prices.
Read more »
2 drug giants are feuding over a highly successful new migraine drug, and court documents reveal how profitable the $10 billion market could beTwo drugmakers, Amgen and Novartis, have worked together for years on a new type of cutting-edge migraine drug, Aimovig.
Read more »
Libya's rival leaders could overcome army control dispute: U.N. Secretary GeneralThere are signs that Libya's two rival leaders may for the first time solve...
Read more »
The job benefit that can lower your health insurance payroll deductionThe wellness industry has been valued at $40 billion globally, and money continues to pour into start-ups focusing on health and wellness. Early results have been encouraging, but there is much to learn about job productivity and the bottom line.
Read more »
LAPD: Nipsey Hussle shooting was result of personal dispute, not gang violenceRapper Nipsey Hussle's shooting death was the result of a personal dispute, not gang violence, police say
Read more »
LAPD: Nipsey Hussle shooting was result of personal dispute, not gang violencePolice chief Michel Moore urged suspect Eric Holder to surrender after Nipsey Hussle's shooting.
Read more »
Take Your Medicine: This $1.5 Billion Health Startup’s Smart Pills Keep Patients From Forgetting
Read more »